Spectral Med Inc
Spectral Medical Inc. focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, Russia, and internationally. The company markets Endotoxin Activity Assay, a rapid in-vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B-Hemoperfusion, a therapeutic hemoperfusion device … Read more
Spectral Med Inc (EDTXF) - Total Assets
Latest total assets as of September 2025: $8.12 Million USD
Based on the latest financial reports, Spectral Med Inc (EDTXF) holds total assets worth $8.12 Million USD as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Spectral Med Inc - Total Assets Trend (1992–2024)
This chart illustrates how Spectral Med Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Spectral Med Inc - Asset Composition Analysis
Current Asset Composition (December 2024)
Spectral Med Inc's total assets of $8.12 Million consist of 83.8% current assets and 16.2% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 56.2% |
| Accounts Receivable | $451.00K | 8.5% |
| Inventory | $229.00K | 4.3% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $175.00K | 3.3% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (1992–2024)
This chart illustrates how Spectral Med Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Spectral Med Inc's current assets represent 83.8% of total assets in 2024, an increase from 82.2% in 1992.
- Cash Position: Cash and equivalents constituted 56.2% of total assets in 2024, down from 64.4% in 1992.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 3.0% of total assets, an increase from 0.0% in 1992.
- Asset Diversification: The largest asset category is accounts receivable at 8.5% of total assets.
Spectral Med Inc Competitors by Total Assets
Key competitors of Spectral Med Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
ADCNF
OTCGREY:ADCNF
|
USA | $4.51 Billion |
|
Berry Genomics Co Ltd
SHE:000710
|
China | CN¥2.34 Billion |
|
Malaysian Genomics Resource
KLSE:0155
|
Malaysia | RM20.70 Million |
|
NSN Co. Ltd
KQ:031860
|
Korea | ₩60.96 Billion |
|
JOONGANG DNM Co.Ltd
KQ:051980
|
Korea | ₩121.79 Billion |
|
GeneMatrix Inc
KQ:109820
|
Korea | ₩28.03 Billion |
|
Genoray Co. Ltd
KQ:122310
|
Korea | ₩125.67 Billion |
|
Green Cross Lab Cell Corporation
KQ:144510
|
Korea | ₩565.79 Billion |
Spectral Med Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - Spectral Med Inc generates 0.43x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Spectral Med Inc is currently not profitable relative to its asset base.
Spectral Med Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.11 | 0.22 | 2.34 |
| Quick Ratio | 0.10 | 0.21 | 2.22 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-60.12 Million | $ -26.63 Million | $ 3.90 Million |
Spectral Med Inc - Advanced Valuation Insights
This section examines the relationship between Spectral Med Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 51.73 |
| Latest Market Cap to Assets Ratio | 26.83 |
| Asset Growth Rate (YoY) | 2.1% |
| Total Assets | $5.32 Million |
| Market Capitalization | $142.75 Million USD |
Valuation Analysis
Premium Asset Valuation: The market values Spectral Med Inc's assets at a significant premium ( 26.83x), suggesting investors see substantial growth potential or unique competitive advantages.
Positive Asset Growth: Spectral Med Inc's assets grew by 2.1% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Spectral Med Inc (1992–2024)
The table below shows the annual total assets of Spectral Med Inc from 1992 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $5.32 Million | +2.09% |
| 2023-12-31 | $5.21 Million | -56.56% |
| 2022-12-31 | $12.00 Million | +3.82% |
| 2021-12-31 | $11.55 Million | +41.55% |
| 2020-12-31 | $8.16 Million | +103.77% |
| 2019-12-31 | $4.01 Million | -42.58% |
| 2018-12-31 | $6.98 Million | +100.89% |
| 2017-12-31 | $3.47 Million | -51.08% |
| 2016-12-31 | $7.10 Million | -16.07% |
| 2015-12-31 | $8.46 Million | -28.69% |
| 2014-12-31 | $11.86 Million | +25.68% |
| 2013-12-31 | $9.44 Million | -25.01% |
| 2012-12-31 | $12.59 Million | -39.05% |
| 2011-12-31 | $20.65 Million | +19.40% |
| 2010-12-31 | $17.30 Million | +243.70% |
| 2009-12-31 | $5.03 Million | -28.98% |
| 2008-12-31 | $7.08 Million | -11.22% |
| 2007-12-31 | $7.98 Million | -14.52% |
| 2006-12-31 | $9.34 Million | -5.64% |
| 2005-12-31 | $9.89 Million | -12.97% |
| 2004-12-31 | $11.37 Million | -34.55% |
| 2003-12-31 | $17.37 Million | -16.04% |
| 2002-12-31 | $20.68 Million | +21.71% |
| 2001-12-31 | $17.00 Million | -18.86% |
| 2000-12-31 | $20.94 Million | +49.32% |
| 1999-12-31 | $14.03 Million | -12.88% |
| 1998-12-31 | $16.10 Million | -34.02% |
| 1997-12-31 | $24.40 Million | -42.59% |
| 1996-12-31 | $42.50 Million | +33.65% |
| 1995-12-31 | $31.80 Million | -22.25% |
| 1994-12-31 | $40.90 Million | -4.44% |
| 1993-12-31 | $42.80 Million | +851.11% |
| 1992-12-31 | $4.50 Million | -- |